Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
paolo.marchetti@uniroma1.it
Paolo Marchetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
paolo.marchetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study
INTEGRATIVE CANCER THERAPIES
2019
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
JOURNAL OF TRANSLATIONAL MEDICINE
2019
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents
EUROPEAN JOURNAL OF PHARMACOLOGY
2019
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors
SUPPORTIVE CARE IN CANCER
2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
CASE REPORTS IN ONCOLOGICAL MEDICINE
2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
THE ONCOLOGIST
2019
Response to: comment on “Impact of tumor site on the prognosis of small bowel adenocarcinoma”
TUMORI
2019
CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer
VIRCHOWS ARCHIV
2019
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab. a real-life multicentre study
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network
EUROPEAN JOURNAL OF CANCER CARE
2019
Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?
CLINICAL ENDOCRINOLOGY
2019
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center
JOURNAL OF CLINICAL MEDICINE
2019
Immunotherapy in non-small cell lung cancer patients: back to the future
RECENTI PROGRESSI IN MEDICINA
2019
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
2019
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience
RADIATION ONCOLOGY
2019
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives
JOURNAL OF HEMATOLOGY & ONCOLOGY
2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
JOURNAL OF TRANSLATIONAL MEDICINE
2019
A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy
ANNALS OF ONCOLOGY
2019
« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma